EFI2023: 36TH EUROPEAN IMMUNOGENETICS AND HISTOCOMPATIBILITY CONFERENCE, « BIG DATA IN IMMUNOGENETICS AT THE CROSSROAD OF CARE, TOOLS, AND RESEARCH »
PROGRAM

Days: Tuesday, April 25th Wednesday, April 26th Thursday, April 27th Friday, April 28th Saturday, April 29th

Tuesday, April 25th

View this program: with abstractssession overviewtalk overview

08:30-17:30 Session 1A: ESHI Diploma Examination

Diploma exams

Chair:
David Turner (Scottish National Blood Transfusion Service, Royal Infirmary Edinburgh, UK)
Location: Room E
08:30-17:30 Session 1B: ESHI Diploma Examination

ESHI Candidate preparation room

Chair:
David Turner (Scottish National Blood Transfusion Service, Royal Infirmary Edinburgh, UK)
Location: Room F
09:00-17:15 Session 2: Inspectors' Workshop

Inspectors' Workshop

Chair:
Blanka Vidan-Jeras (Blood Transfusion Center of Slovenia, Ljubljana, Slovenia)
Location: Room 150
19:00-23:00

Inspectors' dinner (by invitation only)

Wednesday, April 26th

View this program: with abstractssession overviewtalk overview

08:30-16:30 Session 3C: Executive Committee meeting

Executive Committee meeting

Chair:
Ann-Margaret Little (Histocompatibility and Immunogenetics, Laboratory Medicine, Gartnavel General Hospital, Glasgow, UK, UK)
Location: Room D
08:30-16:30 Session 3D: External Proficiency Testing Committee meeting

EPT Committee meeting

Chair:
Helle Bruunsgaard (Department of Clinical Medicine University of Copenhagen, Copenhagen, Denmark, Denmark)
Location: Room E
08:30-17:00 Session 3E: Accreditation Committee meeting

Accreditation Committee meeting

Chair:
Blanka Vidan-Jeras (Blood Transfusion Center of Slovenia, Ljubljana, Slovenia)
Location: Room H
08:30-16:30 Session 3F: Standards Committee meeting

Standards Committee meeting

Chair:
Katy Latham (H&I at NHS Blood and Transplant, Colindale, England, United Kingdom, UK)
Location: Room M
09:00-12:00 Session 4: IT & Bioinformatics Committee meeting

IT & Bioinformatics Committee meeting

Chair:
Eric Spierings (University Medical Center Utrecht, Netherlands)
Location: Room F
10:00-17:00 Session 5

OMIXON User Group Meeting

Location: Room 150
12:15-13:45 Session 6: Open Meeting of the Population Genetics Working Group

Open Meeting of the Population Genetics Working Group

Chair:
Alicia Sanchez-Mazas (University of Geneva, Switzerland)
Location: Room KL
13:00-14:00Lunch Break

Lunch Break

13:30-17:00 Session 7A: Education Committee meeting

Education Committee meeting

Chair:
Deborah Sage (H&I Department, NHS Blood and Transplant, UK, UK)
Location: Room I
13:30-16:30 Session 7B: SFHI Scientific Committee

SFHI Scientific Committee

Location: Auditorium 450
13:30
Jean Villard (Geneva University Hospitals, Switzerland)
Quantification of allelic expression of HLA genes: methods, regulation, and implication in allograft
14:15
Nicolas Vince (CR2TI Nantes Université umr1064, France)
HLA and single-nucleotide polymorphisms: implication in diseases
15:00
Jonathan Visentin (TBC, France)
B-lymphocytes function in chronic graft versus host disease
15:45
Nataliya Yeremenko (tbc, France)
Role of the transcriptional regulator BOB1 in immune tolerance and transplantation
14:00-17:00 Session 8: Scientific Committee meeting

Scientific Committee meeting

Chair:
Luca Vago (IRCCS San Raffaele Scientific Institute, Italy)
Location: Room KL
14:30-16:30 Session 9: Young EFI Working Group meeting

Young EFI Working Group

Chairs:
Arianne Brandsma (Immunogenetics department, Sanquin Diagnostiek B.V, Netherlands, Netherlands)
Timo Olieslagers (Transplantation Immunology, Tissue Typing Laboratory, Maastricht University Medical Center, Maastricht, the Netherlands, Netherlands)
Location: Room G
17:30-19:00 Session 10: OPENING CEREMONY

OPENING CEREMONY

Chairs:
Pierre-Antoine Gourraud (Nantes Université, CR2TI UMR1064, Nantes, France, France)
Ann-Margaret Little (Histocompatibility and Immunogenetics, Laboratory Medicine, Gartnavel General Hospital, Glasgow, UK, UK)
17:30
Ann-Margaret Little (Histocompatibility and Immunogenetics, Laboratory Medicine, Gartnavel General Hospital, Glasgow, UK, UK)
Welcome Addresses
18:00
Luca Vago (IRCCS San Raffaele Scientific Institute, Italy)
Julia Bodmer Award
18:20
Steven Marsh (Anthony Nolan Research Institute, Cancer Institute, University College London, London, UK, UK)
HLA Award
18:30
Ann-Margare Little (Histocompatibility and Immunogenetics, Laboratory Medicine, Gartnavel General Hospital, Glasgow, UK, UK)
Ceppellini Lecture
Thursday, April 27th

View this program: with abstractssession overviewtalk overview

08:00-19:00 Session 12

POSTER AREA

Location: Mezzanine
08:30-10:00 Session 13: Plenary Session I

Cell Therapies & Hematopoietic Stem Cell Transplantation

Chairs:
Katharina Fleischhauer (University Hospital Essen, Germany)
Alexandre Walencik (Histocompatibility and Immunogenetics laboratory, EFS Centre-Pays de la Loire, Nantes, France, France)
08:30
Florent Malard (Sorbonne Université, Hôpital Saint-Antoine, AP-HP, Paris, France, France)
How cell therapy has been implemented in Europe, evolution from classical to new therapies.
09:00
Robert Zeiser (Hematology and Oncology, University Medical Center Freiburg, Germany, Germany)
The graft-versus-host disease (GVHD): Novel developments in GVHD therapy.
09:30
Carole Guillonneau (Nantes Université, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France, France)
Advancing T cell therapies (CAR T-cell immunotherapies).
10:00-10:30Coffee Break

Coffee Break

10:30-12:00 Session 14A: Teaching Session: Innvation in Transplantation

Innovation in Transplantation

Chairs:
Martijn van den Hoogen (Division of Lung Transplantation & Erasmus MC Transplant Institute, Rotterdam, The Netherlands, Netherlands)
Begoña Aran (Barcelona Stem Cell Bank, Regenerative Medicine Programme, Bellvitge Biomedical Research Institute (IDIBELL), Spain)
Paul-Olivier Rouzaire (Department of Histocompatibility & Immunogenetics, Clermont Auvergne University, France, France)
Location: Room 300
10:30
Martijn van den Hoogen (Division of Lung Transplantation & Erasmus MC Transplant Institute, Rotterdam, The Netherlands, Netherlands)
Telemedicine in renal transplantation: Innovations for 2023 and beyond.
11:00
Begoña Aran (Barcelona Stem Cell Bank, Regenerative Medicine Programme, Bellvitge Biomedical Research Institute (IDIBELL), Spain)
Generation Of Human Induced Pluripotent Stem Cells From Haplo-Selected Cord Blood Samples (HAPLO-iPS).
11:30
Paul-Olivier Rouzaire (Department of Histocompatibility & Immunogenetics, Clermont Auvergne University, France, France)
Temporal regulation of transgene expression controlled by amino acid availability in human T cells.
10:30-12:00 Session 14B: Special Joint EFI-ESOT session

The use of AI to assist decision-making in transplantation

Chairs:
Kay Poulton (Transplantation Laboratory, Manchester Royal Infirmary, Manchester, UK)
Gilles Blancho (Nantes Université, CHU Nantes, Inserm, CR2TI, UMR 1064, ITUN, France)
10:30
Gabriel Oniscu (Karolinska Institutet Stockholm, Sweden, Sweden)
The ESOT initiative to build pan-European registries in SOT: why? how? where are we standing?
11:00
Sophie Limou (Nantes Université, Centrale Nantes, CR2TI, UMR 1064, Nantes, France, France)
The use of genomic to assist decision-making in transplantation.
11:30
Jasper Callemeyn (Nephrology and Renal Transplantation Research Group, KU Leuven, Belgium, Belgium)
Refining the diagnosis of rejection by artificial intelligence.
10:30-12:00 Session 14C: Abstract Session: MHC Evolution, Population Genetics (O9 - O16)

MHC Evolution, Population Genetics

Chairs:
Emmanuelle Génin (INSERM UMR1078, UFR Médecine, Université de Bretagne Occidentale, France)
Alicia Sanchez-Mazas (University of Geneva, Switzerland)
Location: Auditorium 450
10:30
Da Di (Anthropology Unit, Department of Genetics and Evolution, University of Geneva, Geneva, Switzerland)
Pascale Gerbault (Anthropology Unit, Department of Genetics and Evolution, University of Geneva, Geneva, Switzerland)
Ndeye Khady Faye (Anthropology Unit, Department of Genetics and Evolution, University of Geneva, Geneva, Switzerland)
Wassim Almawi (Abu Dhabi University, Abu Dhabi, UAE)
Marco Andreani (IRCCS Ospedale Pediatrico Bambino Gesùm, Rome, Italy)
Esteban Arrieta-Bolanos (University Hospital Essen, Essen, Germany)
Danillo G. Augusto (Universidade Federal do Paraná, Paraná, Brazil)
Stéphane Buhler (Hôpitaux Universitaires de Genève, Geneva, Switzerland)
Roberto Diaz Pena (Universidad Autónoma de Chile, Talca, Chile)
Selma D'Silva (Advanced Centre for Treatment, Research and Education in Cancer, India)
Valérie Dubois (EFS Auvergne-Rhône-Alpes, Décine-Charpieu, France)
Gehad Eltayeb Elghazali (Sheikh Khalifa Medical City, UAE)
Clara Gorodezky (Fundación Comparte Vida, Mexico City, Mexico)
Zorana Grubic (University Hospital Centre Zagreb, Zagreb, Croatia)
Ali Hajeer (King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia)
Jill Hollenbach (University of California, San Francisco, United States)
Hellen C. Issler (Universidade Federal do Paraná, Paraná, Brazil)
Milena Ivanova (University Hospital Alexandrovska, Sofia, Bulgaria)
Dunia Jawdat (King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia)
Uma Kanga (All India Institute of Medical Sciences, New Dehli, India)
Meri Kirijas (Biomedica Dijagnostika, Skopje, Macedonia)
William Lemieux (Héma-Québec, Saint-Laurent, Canada)
Maria Loginova (Scientific-research Inst. Hermatology & Blood Transfusion of FMBA, Kirov, Russia)
Nadia Mahfoudh (Faculté de Médecine de Sfax, Sfax, Tunisia)
Narinder Mehra (All India Institute of Medical Sciences, New Dehli, India)
Delphine Mouron (Hôpitaux Universitaires de Genève, Geneva, Switzerland)
Martin Petrek (Palacký University Olomouc, Olomouc, Czechia)
Maria Luiza Petzl-Erler (Universidade Federal do Paraná, Paraná, Brazil)
Lucie Richard (Héma-Québec, Saint-Laurent, Canada)
Dave L. Roelen (Leiden University Medical Center, Leiden, Netherlands)
Nicoletta Sacchi (E. O. Ospedali Galliera, Genova, Italy)
Akanksha Sharma (All India Institute of Medical Sciences, New Dehli, India)
Bisu Singh (Sikkim University, India)
Meenakshi Singh (Advanced Centre for Treatment, Research and Education in Cancer, Mumbai, India)
Yoginder Singh (All India Institute of Medical Sciences, New Delhi, India)
Katerina Tarassi (Evangelismos Hospital, Athens, Greece)
Christelle Vangenot (Anthropology Unit, Department of Genetics and Evolution, University of Geneva, Geneva, Switzerland)
Blanka Vidan-Jeras (Blood Transfusion Center of Slovenia, Ljubljana, Slovenia)
Linda Vigilant (Max Planck Institute for Evolutionary Biology, Leipzig, Germany)
Emily Wroblewski (Washington University, Washington, United States)
Jean Villard (Hôpitaux Universitaires de Genève, Geneva, Switzerland)
Natasja de Groot (BPRC, Rijswijk, Netherlands)
José Manuel Nunes (Anthropology Unit, Department of Genetics and Evolution, University of Geneva, Geneva, Switzerland)
Alicia Sanchez-Mazas (Anthropology Unit, Department of Genetics and Evolution, University of Geneva, Geneva, Switzerland)
From global population genetic profiles to detailed individual molecular variation in humans and chimpanzees: a new turn in our understanding of MHC diversity and evolution (abstract)
10:40
Nicholas R. Pollock (University of Colorado, United States)
Stephan Scholz (Heinrich Heine University Düsseldorf, Germany)
Katherine M. Kichula (University of Colorado, United States)
William Palmer (University of Colorado, United States)
Ticiana D.J. Farias (University of Colorado, United States)
Ana C. Codo (University of Colorado, United States)
Peter Parham (Stanford University, United States)
Lisbeth A. Guethlein (Stanford University, United States)
Alexander Dilthey (Heinrich Heine University Düsseldorf, Germany)
Paul J. Norman (University of Colorado, United States)
CREATING FULLY REPRESENTATIVE MHC REFERENCE HAPLOTYPES (abstract)
10:50
Anja Klussmeier (DKMS Life Science Lab, Dresden, Germany, Germany)
Kathrin Putke (DKMS Life Science Lab, Dresden, Germany, Germany)
Steffen Klasberg (DKMS Life Science Lab, Dresden, Germany, Germany)
Maja Kohler (DKMS Life Science Lab, Dresden, Germany, Germany)
Gerhard Schöfl (DKMS Life Science Lab, Dresden, Germany, Germany)
Alexander H. Schmidt (DKMS Life Science Lab, Dresden, Germany; DKMS, Tübingen, Germany, Germany)
Axel Roers (Institute for Immunology, TU Dresden, Germany; Institute for Immunology, University Hospital Heidelberg, Germany, Germany)
Vinzenz Lange (DKMS Life Science Lab, Dresden, Germany, Germany)
MICA Copy Number Variations are the Result of Numerous Independent Non-Allelic Homologous Recombination Events (abstract)
PRESENTER: Anja Klussmeier
11:00
Anja Klussmeier (DKMS Life Science Lab, Dresden, Germany, Germany)
Jürgen Sauter (DKMS, Tübingen, Germany, Germany)
Alexander H. Schmidt (DKMS Life Science Lab, Dresden, Germany; DKMS, Tübingen, Germany, Germany)
Vinzenz Lange (DKMS Life Science Lab, Dresden, Germany, Germany)
High Frequency of MICA Gene Deletion Haplotypes in Several Non-European Populations (abstract)
PRESENTER: Anja Klussmeier
11:10
Katarzyna Bogunia-Kubik (Hirszfled Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland, Poland)
Marta Dratwa (Hirszfled Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland, Poland)
Bushra Al Hadraa (University Hospital Alexandrovska, Medical University, Sofia, Bulgaria, Bulgaria)
Fatma Oguz (Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey, Turkey)
Yeliz Ogret (Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey, Turkey)
Ileana Constantinescu (Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, Romania)
Dimitri Apostol (Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, Romania)
Adriana Talangescu (Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, Romania)
Alexandra-Elena Constantinescu (Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, Romania)
Ion Maruntelu (Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, Romania)
Katarzyna Koscinska (HLA Laboratory, Lower Silesian Oncology, Pulmonology and Hematology Center, Wroclaw, Poland, Poland)
Tsvetelin Lukanov (University Hospital Alexandrovska,Medical University, Sofia, Bulgaria, Bulgaria)
Elissaveta Naumova (University Hospital Alexandrovska, Medical University, Sofia, Bulgaria, Bulgaria)
Telomeres and ageing and their relation with HLA – results from the project “Immunogenetics of Ageing” within 18th IHIWS (abstract)
11:20
Yang Luo (University of Oxford, UK)
Xinyi Li (University of Chicago, United States)
Jerome Rotter (The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, United States)
Kent Taylor (The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, United States)
Josyf Mychaleckyj (University of Virginia School of Medicine Charlottesville, United States)
Stephen Rich (University of Virginia School of Medicine Charlottesville, United States)
Nhlbi Trans-Omics For Precision Medicine Consortium (TOPMed, United States)
John Novembre (University of Chicago, United States)
Soumya Raychaudhuri (Havard Medical School, United States)
Classical HLA alleles and long-range haplotypes are under rapid selection among admixed populations (abstract)
PRESENTER: Yang Luo
11:30
Bruno Lima (Oficina de Bioestatistica, Transplant Open registry, Portugal)
Human Leukocyte Antigens (HLA) evolutionary divergence (HED) calculator (abstract)
11:40
Kristen J. Wade (University of California San Francisco, United States)
Danillo G. Augusto (UNC Charlotte, United States)
Kerry Kizer (University of California San Francisco, United States)
Tasneem Yusufali (University of California San Francisco, United States)
Juliano Boquett (University of California San Francisco, United States)
Stacy Callier (University of California San Francisco, United States)
Jorge R. Oksenberg (University of California San Francisco, United States)
Jill A. Hollenbach (University of California San Francisco, United States)
A high-throughput approach to the MHC assembly challenge in disease association (abstract)
PRESENTER: Kristen J. Wade
10:30-12:00 Session 14D: Abstract Session: New technologies & New Approaches in Immunogenetics (O17 - O24)

New technologies & New Approaches in Immunogenetics

Chairs:
Silvia Gregori (San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Italy)
Florent Delbos (Histocompatibility and Immunogenetics laboratory, EFS Centre-Pays de la Loire, Nantes, France, France)
Location: Room 200
10:30
Jonathan A.M. Lucas (Anthony Nolan Research Institute, Royal Free Hospital, London, UK, UK)
Richard M. Szydlo (Anthony Nolan Research Institute, Royal Free Hospital and Department of Medicine, Imperial College, London, UK, UK)
Shelley Hewerdine (Anthony Nolan Research Institute, Royal Free Hospital, London, UK, UK)
Steven G.E. Marsh (Anthony Nolan Research Institute, Royal Free Hospital, London, UK, UK)
Neema P. Mayor (Anthony Nolan Research Institute, Royal Free Hospital, London, UK, UK)
The beneficial impact of HLA-E mismatching for patients receiving a less than 10/10 HLA matched hematopoietic cell transplant. (abstract)
10:40
Pascal Pedini (Immunogenetics Laboratory, Etablissement Français du Sang, Marseille, France)
Benjamin Coiffard (Lung transplant department, APHM, Marseille, France)
Sylvia Casas (CareDx, Brisbane, United States)
Audrey Boutonnet (ADELIS Tech, Labege,, France)
Agnès Basire (Immunogenetics Laboratory, Etablissement Français du Sang, Marseille, France)
Sophie Simon (Immunogenetics Laboratory, Etablissement Français du Sang, Marseille, France)
Lucas Hubert (Immunogenetics Laboratory, Etablissement Français du Sang, Marseille, France)
Coralie Frassati (Immunogenetics Laboratory, Etablissement Français du Sang, Marseille, France)
Jacques Chiaroni (Immunogenetics Laboratory, Etablissement Français du Sang, Marseille, France)
Martine Reynaud-Gaubert (Lung transplant department, APHM, Marseille, France)
Christophe Picard (Immunogenetics Laboratory, Etablissement Français du Sang, Marseille, France)
Clinical relevance of cell-free DNA quantification and qualification during the first month after lung transplantation (abstract)
PRESENTER: Pascal Pedini
10:50
Matilda Tierney (Anthony Nolan Research Institute, UK)
Thomas Turner Turner (Anthony Nolan Research Institute and UCL Cancer Institute, UK)
Gabriel Benitez (Anthony Nolan Research Institute, UK)
Dominic Barker (Anthony Nolan Research Institute, UK)
Neema Mayor (Anthony Nolan Research Institute and UCL Cancer Institute, UK)
Steven Marsh (Anthony Nolan Research Institute and UCL Cancer Institute, UK)
Full-gene sequence characterisation of HLA-DMA, -DMB, -DOA, and -DOB in a panel of International HLA and Immunogenetics Workshop cell lines (abstract)
PRESENTER: Matilda Tierney
11:00
Stefan Schaub (University Hospital Basel, Switzerland)
Randomized trial to assess the clinical utility of renal allograft monitoring by urine CXCL10 chemokine (abstract)
11:10
Corrine Heijmans (BPRC, Netherlands)
Jesse Bruijnesteijn (BPRC, Netherlands)
Natasja G. de Groot (BPRC, Netherlands)
Ronald E. Bontrop (BPRC, Netherlands)
Characterization of chimpanzee KIR haplotype organizations using Cas9 enrichment and Oxford Nanopore sequencing. (abstract)
PRESENTER: Corrine Heijmans
11:20
Matěj Röder (Institute for Clinical and Experimental Medicine, Prague, Czechia)
Antonij Slavčev (Institute for Clinical and Experimental Medicine, Prague, Czechia)
Jan Kubant (Mild Blue s.r.o., Czechia)
Tomáš Kouřim (Faculty of Nuclear Science and Physical Engineering, Czech Technical University in Prague, Czechia)
Aneta Glosová (Institute for Clinical and Experimental Medicine, Prague, Czechia)
Tereza Jančušková (Institute for Clinical and Experimental Medicine, Prague, Czechia)
Kateřina Jáklová (Institute for Clinical and Experimental Medicine, Prague, Czechia)
Ondřej Viklický (Institute for Clinical and Experimental Medicine, Prague, Czechia)
Petr Raška (Institute for Clinical and Experimental Medicine, Prague, Czechia)
Jiří Froněk (Institute for Clinical and Experimental Medicine, Prague, Czechia)
TXMatching – a novel software for kidney paired donations (abstract)
PRESENTER: Matěj Röder
11:30
Job Geerligs (GenDx, Netherlands)
Lisa Rond (GenDx, Netherlands)
Fereshte Dadkhodaie (GenDx, Netherlands)
Gijsbert Keja (GenDx, Netherlands)
Maarten Penning (GenDx, Netherlands)
Loes van de Pasch (GenDx, Netherlands)
Sake van Wageningen (GenDx, Netherlands)
HLA loss detection by NGS using STR markers within the MHC region on chromosome 6 (abstract)
11:40
Colin Brown (NHS Blood and Transplant, UK)
Shane Grimsley (NHS Blood and Transplant, UK)
Nicholas Gleadall (University of Cambridge, UK)
Trevor Green (NHS Blood and Transplant, UK)
Furkhana Cheriyalampady-House (NHS Blood and Transplant, UK)
John Ord (University of Cambridge, UK)
Martin Howell (NHS Blood and Transplant, UK)
Lydia Quaye (NHS Blood and Transplant, UK)
Andrea Harmer (NHS Blood and Transplant, UK)
Assessment of a Universal Blood Donor Genotyping Platform (abstract)
PRESENTER: Colin Brown
12:00-12:10Coffee Break

Coffee Break 

12:00-14:30 Session 15A: EFI Executive Committee and Coordinators meeting

EFI Executive Committee and Coordinators meeting

Chair:
Ann-Margaret Little (Histocompatibility and Immunogenetics, Laboratory Medicine, Gartnavel General Hospital, Glasgow, UK, UK)
Location: Room G
12:00-14:00 Session 15B: SHLARC Consortium meeting

SHLARC Consortium meeting

Chairs:
Nicolas Vince (Nantes Université, CR2TI UMR1064, Nantes, France, France)
Pierre-Antoine Gourraud (Nantes Université, CR2TI UMR1064, Nantes, France, France)
Location: Room J
12:10-13:10 Session 16: Luncheon Industry Symposium: CareDx

Luncheon Industry Symposium: CareDx

Location: Room 300
13:20-14:20 Session 17: Luncheon Industry Symposium: Immucor

Luncheon Industry Symposium: Immucor

Location: Room 300
13:30-14:30 Session 18: ETHIQ Diploma meeting

ETHIQ Diploma meeting

Chair:
Deborah Sage (H&I Department, NHS Blood and Transplant, UK, UK)
Location: Room I
14:20-14:30Coffee Break

Coffee Break

14:30-16:00 Session 19A: Teaching Session: Anthropology & Population Genetics

Anthropology & Population Genetics: Immunogenetic diversity of the HLA system

Chairs:
Emmanuelle Génin (INSERM UMR1078, UFR Médecine, Université de Bretagne Occidentale, France)
Erick C. Castelli (Molecular Genetics and Bioinformatics Laboratory, Experimental Research Unity, School of Medicine, UNESP, Brazil)
Location: Room 300
14:30
Emmanuelle Génin (INSERM UMR1078, UFR Médecine, Université de Bretagne Occidentale, France)
Genetic diversity in metropolitan France at the beginning of the 20th century: the POPGEN project
15:00
Erick Castelli (Department of Pathology, School of Medicine, São Paulo State University (Unesp), Botucatu, State of São Paulo, Brazil, Brazil)
HLA genetic diversity and the challenges for analyzing highly polymorphic and repetitive genes.
14:30-16:00 Session 19B: Special Joint EFI-NAT Session: Control of The Immune System in Transplantation

Special Session 2: NAT "Control of the immune system in Transplantation"

Chairs:
Jean Villard (Division of Nephrology & Transplantation Immunology, University Hospital of Geneva, Geneva, Switzerland, Switzerland)
Magali Giral (CHU Nantes, Université de Nantes, INSERM, CR2TI, UMR 1064, ITUN, Nantes, France, France)
14:30
Alberto Sanchez Fueyo (The Institute of Liver Studies at King’s College London, UK, UK)
Regulatory T cells, translation to the clinic.
15:00
Mübeccel Akdis (Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Switzerland, Switzerland)
Regulatory B cells, where we are?
15:30
Sophie Hillion (U1227, LBAI, Univ Brest, Inserm, and CHU Brest, Brest, France, France)
B cell functional subsets from autoimmunity to transplantation
14:30-16:00 Session 19C: Abstract Session: NK Cells & KIR (O25-O32)

NK Cells & KIR

Chairs:
Christelle Retière (Nantes Université, EFS, INSERM, CNRS, CRCI2NA, 44000, Nantes, France, France)
Danillo Augusto (University of North Carolina at Charlotte, USA, United States)
Location: Auditorium 450
14:30
Jesse Bruijnesteijn (Biomedical Primate Research Centre, Netherlands)
Marit van der Wiel (Biomedical Primate Research Centre, Netherlands)
Nanine de Groot (Biomedical Primate Research Centre, Netherlands)
Natasja de Groot (Biomedical Primate Research Centre, Netherlands)
Ronald Bontrop (Biomedical Primate Research Centre, Netherlands)
Chromosomal rearrangements in the KIR gene cluster as evolutionary strategy to protect against evading pathogens (abstract)
14:40
Marit van der Wiel (Biomedical Primate Research Centre, Netherlands)
Jesse Bruijnesteijn (Biomedical Primate Research Centre, Netherlands)
Nanine de Groot (Biomedical Primate Research Centre, Netherlands)
Natasja de Groot (Biomedical Primate Research Centre, Netherlands)
Ronald Bontrop (Biomedical Primate Research Centre, Netherlands)
Variegated expression of KIR regulated by conserved and diverged promoter regions in humans and macaques (abstract)
14:50
Ticiana Dj Farias (University of Colorado, United States)
Silvia Brugiapaglia (University of Turin, Italy)
Susanna Croci (University of Siena, Italy)
Paola Magistroni (Città della Salute e della Scienza di Torino, Italy)
Claudia Curcio (University of Turin, Italy)
Kristina Zguro (University of Siena, Italy)
Chiara Fallerini (University of Siena, Italy)
Francesca Fava (University of Siena, Italy)
Francesco Pettini (University of Siena, Italy)
Katherine M Kichula (University of Colorado, United States)
Nicholas R Pollock (University of Colorado, United States)
William H Palmer (University of Colorado, United States)
Wesley M Marin (University of California, United States)
Margherita Baldassarri (University of Siena, Italy)
Mirella Bruttini (University of Siena, Italy)
Jill Hollenbach (University of California, San Francisco, United States)
Audrey E Hendricks (University of Colorado, United States)
Ilaria Meloni (University of Siena, Italy)
Francesco Novelli (University of Turin, Italy)
Alessandra Renieri (University of Siena, Italy)
Simone Furini (University of Siena, Italy)
Antonio Amoroso (AOU Città della Salute e della Scienza di Torino, Italy)
Paul Norman (University of Colorado, United States)
Polymorphism of HLA and KIR affects severity of COVID-19 by shaping innate and adaptive immunity to SARS-CoV-2 (abstract)
15:00
Amber Lombardi (MUMC+, Netherlands)
Denise Habets (MUMC+, Netherlands)
Marc Spaanderman (MUMC+, Radboud UMC, Netherlands)
Salwan Al-Nasiry (MUMC+, Netherlands)
Lotte Wieten (MUMC+, Netherlands)
The role of natural killer cells in recurrent pregnancy loss: evaluation of natural killer cell education (abstract)
PRESENTER: Amber Lombardi
15:10
Jairo Eduardo Niño Ramirez (Servicio de Hematología, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Spain, Spain)
Miguel Alcoceba (Servicio de Hematología, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Spain, Spain)
Nieves Gutiérrez-Zufiaurre (Servicio de Microbiología, Hospital Universitario de Salamanca, IBSAL, USAL, Spain, Spain)
Miguel Marcos (Servicio de Medicina Interna, Hospital Universitario de Salamanca, IBSAL, Spain, Spain)
Rocio Bartol Sánchez (Servicio de Neumología, Hospital Universitario de Salamanca, Spain., Spain)
Rocio Eiros (Servicio de Cardiología, Hospital Universitario de Salamanca, IBSAL, USAL, CIBERCV, Spain., Spain)
María García-Alvarez (Servicio de Hematología, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Spain, Spain)
Pilar Terradillos Sánchez (Servicio de Hematología, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Spain, Spain)
Daniel Presa (Servicio de Hematología, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Spain, Spain)
Juan Luis Muñoz (Servicio de Microbiología, Hospital Universitario de Salamanca, IBSAL, USAL, Spain, Spain)
Amparo López Bernús (Servicio de Medicina Interna, Hospital Universitario de Salamanca, IBSAL, Spain, Spain)
Eugenia López Sánchez (Servicio de Medicina Interna, Hospital Universitario de Salamanca, IBSAL, Spain, Spain)
David González Calle (Servicio de Cardiología, Hospital Universitario de Salamanca, IBSAL, USAL, CIBERCV, Spain., Spain)
Pedro Luis Sánchez (Servicio de Cardiología, Hospital Universitario de Salamanca, IBSAL, USAL, CIBERCV, Spain., Spain)
Olga Compán Fernández (Servicio de Reumatología, Hospital Universitario de Salamanca, Spain., Spain)
Marcos González (Servicio de Hematología, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Spain, Spain)
Ramón García-Sanz (Servicio de Hematología, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Spain, Spain)
Francisco Boix (Servicio de Hematología, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Spain, Spain)
KIR2DL2/C1: a potential predictive immunogenetic marker to COVID-19 severity in Spanish patients (abstract)
15:20
Kathrin Putke (DKMS Life Science Lab, Dresden, Germany, Germany)
Steffen Klasberg (DKMS Life Science Lab, Dresden, Germany, Germany)
Georg Girke (DKMS Life Science Lab, Dresden, Germany, Germany)
Alexander H. Schmidt (DKMS Life Science Lab, Dresden, Germany; DKMS; Tübingen, Germany, Germany)
Anja Klussmeier (DKMS Life Science Lab, Dresden, Germany, Germany)
Vinzenz Lange (DKMS Life Science Lab, Dresden, Germany, Germany)
Nanopores may replace SMRT reads for dual redundant reference sequencing (DR2S): Characterization of more than 600 novel KIR alleles (abstract)
PRESENTER: Kathrin Putke
15:30
Leonardo Amorim (Universidade Federal do Paraná, Brazil, Brazil)
Marcia Beltrame (Universidade Federal do Paraná, Brazil, Brazil)
Enilze Ribeiro (Universidade Federal do Paraná, Brazil, Brazil)
Jill Hollenbach (University of California San Francisco, USA, United States)
Danillo Augusto (University of North Carolina at Charlotte, USA, United States)
Natural killer cell receptor variation is associated with more aggressive subtypes of breast cancer (abstract)
PRESENTER: Danillo Augusto
15:40
Nicky Beelen (Maastricht University, Netherlands)
Stefan Molenbroeck (MUMC+, Netherlands)
Lisette Groeneveld (MUMC+, Netherlands)
Christien Voorter (MUMC+, Netherlands)
Lotte Wieten (MUMC+, Netherlands)
HLA class I epitope and KIR diversities in multiple myeloma (abstract)
PRESENTER: Nicky Beelen
14:30-16:00 Session 19D: Abstract Session: Immunogenetics in Organ Transplantation (O33-O40)

Immunogenetics in Organ Transplantation

Chairs:
Anat Tambur (Feinberg School of Medicine, Northwestern University, Chicago, USA, United States)
Carole Guillonneau (Nantes Université, CR2TI UMR 1064, Nantes, France, France)
Location: Room 200
14:30
Sophie Limou (Nantes Université, INSERM, Ecole Centrale Nantes, CHU Nantes, CR2TI, UMR 1064, Nantes, France)
Justine Baron (Nantes Université, INSERM, Ecole Centrale Nantes, CHU Nantes, CR2TI, UMR 1064, Nantes, France)
Afaf Tissafi-Idrissi (Nantes Université, INSERM, Ecole Centrale Nantes, CHU Nantes, CR2TI, UMR 1064, Nantes, France)
Vincent Mauduit (Nantes Université, INSERM, Ecole Centrale Nantes, CHU Nantes, CR2TI, UMR 1064, Nantes, France)
Axelle Durand (Nantes Université, INSERM, Ecole Centrale Nantes, CHU Nantes, CR2TI, UMR 1064, Nantes, France)
Gilles Blancho (Nantes Université, INSERM, Ecole Centrale Nantes, CHU Nantes, CR2TI, UMR 1064, Nantes, France)
Magali Giral (Nantes Université, INSERM, Ecole Centrale Nantes, CHU Nantes, CR2TI, UMR 1064, Nantes, France)
Venceslas Douillard (Nantes Université, INSERM, Ecole Centrale Nantes, CHU Nantes, CR2TI, UMR 1064, Nantes, France)
Nicolas Vince (Nantes Université, INSERM, Ecole Centrale Nantes, CHU Nantes, CR2TI, UMR 1064, Nantes, France)
Immunogenomic exploration in a large kidney transplantation genetic cohort reveals a kidney graft failure association with HLA-B*40:01 and KIRD2L2/HLA-C2 combination (abstract)
PRESENTER: Nicolas Vince
14:40
Uma Kanga (All India Institute of Medical Sciences, India)
Akanksha Sharma (All India Institute of Medical Sciences, India)
Sanjay Agarwal (Dept of Nephrology, AIIMS, New Delhi, India)
Prashanth Suravajhala (Amrita School of Biotechnology, Kerala, India)
Ajay Baranwal (Armed Forces Medical College, Pune, India)
Soumita Bagchi (Dept of Nephrology, AIIMS, New Delhi, India)
Gaurav Sharma (PGIMER, Chandigarh, India)
In the era of precision medicine: lncRNAs as probable biomarkers to predict allograft rejection (abstract)
PRESENTER: Uma Kanga
14:50
Burcu Duygu (Maastricht University Medical Centre, Netherlands)
Mathijs Groeneweg (Maastricht University Medical Centre, Netherlands)
Myrurgia Adul-Hamid (Maastricht University Medical Centre, Netherlands)
Leon C van Kempen (University Hospital Antwerp, Belgium)
Marielle A Gelens (Maastricht University Medical Centre, Netherlands)
Maarten H Christiaans (Maastricht University Medical Centre, Netherlands)
Christina Em Voorter (Maastricht University Medical Centre, Netherlands)
Lotte Wieten (Maastricht University Medical Centre, Netherlands)
Gene expression profiles in 3 month biopsies associate with progression to kidney transplant rejection before detection of histological changes (abstract)
15:00
Monica Sorbini (University of Turin Department of Medical Sciences, Italy)
Gabriele Maria Togliatto (University of Turin Department of Medical Sciences, Italy)
Damiano Patrono (Department of General Surgery, Liver Transplant Center, Città della Salute e della Scienza University Hospital, Italy)
Tullia Carradori (University of Turin Department of Medical Sciences, Italy)
Elena Vissio (University of Turin Department of Medical Sciences, Italy)
Cristiana Caorsi (Immunogenetics and Transplant Biology Service, Città della Salute e della Scienza University Hospital, Italy)
Morteza Mansouri (Immunogenetics and Transplant Biology Service, Città della Salute e della Scienza University Hospital, Italy)
Luisa Delsedime (Department of Oncology, University of Turin, Italy)
Antonio Amoroso (Immunogenetics and Transplant Biology Service, Città della Salute e della Scienza University Hospital, Italy)
Renato Romagnoli (Department of General Surgery, Liver Transplant Center, Città della Salute e della Scienza University Hospital, Italy)
Tiziana Vaisitti (University of Turin Department of Medical Sciences, Italy)
Silvia Deaglio (Immunogenetics and Transplant Biology Service, Città della Salute e della Scienza University Hospital, Italy)
Precision medicine in liver transplant recipients: donor cell-free DNA as an early marker of post-transplant hepatic injury (abstract)
PRESENTER: Monica Sorbini
15:10
Monica Sorbini (University of Turin Department of Medical Sciences, Italy)
Gabriele Maria Togliatto (University of Turin Department of Medical Sciences, Italy)
Tullia Carradori (University of Turin Department of Medical Sciences, Italy)
Cristiana Caorsi (Immunogenetics and Transplant Biology Service, Città della Salute e della Scienza University Hospital, Turin, Italy)
Morteza Mansouri (Immunogenetics and Transplant Biology Service, Città della Salute e della Scienza University Hospital, Turin, Italy)
Antonio Amoroso (AOU Città della Salute e della Scienza di Torino, Italy)
Tiziana Vaisitti (University of Turin Department of Medical Sciences, Italy)
Enrico Aidala (Pediatric and Congenital Cardiac Surgery Child Pathology and Care Department, Regina Margherita Children’s Hospital, Italy)
Carlo Pace Napoleone (Pediatric and Congenital Cardiac Surgery Child Pathology and Care Department, Regina Margherita Children’s Hospital, Italy)
Silvia Deaglio (AOU Città della Salute e della Scienza di Torino, Italy)
Acute and chronic rejection monitoring of pediatric heart transplant recipients through a ddPCR assay based on HLA-DRB1 polymorphism (abstract)
PRESENTER: Monica Sorbini
15:20
Vincent Mauduit (Center for Research in Transplantation and Translational Immunology, France)
Axelle Durand (Center for Research in Transplantation and Translational Immunology, France)
Martin Morin (Center for Research in Transplantation and Translational Immunology, France)
Olivia Rousseau (Center for Research in Transplantation and Translational Immunology, France)
Pierre-Antoine Gourraud (Center for Research in Transplantation and Translational Immunology, France)
Nicolas Vince (Center for Research in Transplantation and Translational Immunology, France)
Gilles Blancho (CHU de Nantes, France)
Magali Giral (CHU de Nantes, France)
Géraldine Jean (Laboratoire des Sciences du Numérique de Nantes, France)
Mathieu Ribatet (Ecole Centrale de Nantes, France)
Sophie Limou (Center for Research in Transplantation and Translational Immunology, France)
Genome-wide survival study identifies a novel association between donor genotype and antibody-mediated kidney graft rejection (abstract)
PRESENTER: Vincent Mauduit
15:30
Michiel Betjes (Erasmus Medical Center Rotterdam, Netherlands)
Emma Peereboom (UMC Utrecht, Netherlands)
Henny Otten (University Medical Center Utrecht, Netherlands)
Eric Spierings (University Medical Center Utrecht, Netherlands)
The number of donor HLA-derived T-cell epitopes available for indirect antigen presentation determines the risk for vascular rejection after kidney transplantation (abstract)
PRESENTER: Emma Peereboom
15:40
Cyrille Feray (Centre Hépato-Biliaire, Hôpital Paul-Brousse, AP-HP, Université Paris-Saclay, Villejuif, France, France)
Vincent Allain (Laboratoire d’Immunologie et Histocompatibilité, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France., France)
Jean-Luc Taupin (Laboratoire d’Immunologie et Histocompatibilité, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France., France)
Christophe Desterke (Centre Hépato-Biliaire, Hôpital Paul-Brousse, AP-HP, Université Paris-Saclay, Villejuif, France, France)
Didier Samuel (Centre Hépato-Biliaire, Hôpital Paul-Brousse, AP-HP, Université Paris-Saclay, Villejuif, France, France)
Sophie Caillat-Zucman (Laboratoire d’Immunologie et Histocompatibilité, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Paris, France., France)
Impact of HLA diversity on humoral response to SARS-Cov-2 and HBV vaccines in liver transplant recipients (abstract)
PRESENTER: Jean-Luc Taupin
16:00-16:30Coffee Break

Coffee Break

16:30-18:00 Session 20: Plenary Session II

HLA Immunogenetics, Population genetics & Evolution

Chairs:
Pierre-Antoine Gourraud (Nantes Université, CR2TI UMR1064, Nantes, France, France)
Lotte Wieten (MUMC+, Netherlands)
16:30
Julian Knight (Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, UK, UK)
HLA and individual response to infection and vaccination
17:00
Patrick Sulem (deCODE genetics,Reykjavik, Iceland, Iceland)
Gene, transcript and proteins to understand immune diseases.
17:30
Corey T Watson (Department of Biochemistry and Molecular Genetics, University of Louisville School of Medicine, United States)
Illuminating the dark corners of the immune system: novel approaches for characterizing haplotype diversity in the T cell receptor and immunoglobulin loci.
18:00-20:00 Session 21: Poster Viewing Session

P1 – P21 - Autoimmunity, Infection, Reproduction & Cancer

P22 – P43 - Bioinformatics, Data Analysis in Immunogenetics

P44 – P67 - Hematopoietic Stem Cell Transplantation (HSCT)

P68 – P82 - Immunogenetics in Organ Transplantation

P83 – P109 - MHC Evolution, Population Genetics

P110 – P117 - NK cells & KIR

P118 – P130 - New Technologies & New Approaches in Immunogenetics

Location: Mezzanine
19:00-23:00 Ceppellini (by invitation only)

Ceppellini (by invitation only)

19:00-23:00 Speakers dinner (by invitation only)

Speakers dinner (by invitation only)

Friday, April 28th

View this program: with abstractssession overviewtalk overview

08:00-19:00 Session 23

POSTER AREA

Location: Mezzanine
08:30-10:00 Session 24: Plenary Session III

HLA in Solid Organ Transplantation

Chairs:
Sebastiaan Heidt (LUMC, Netherlands)
Gwendaline Guidicelli (Laboratoire d'Immunologie et Immunogénétique CHU de Bordeaux, Bordeaux, France, France)
08:30
Seiamak Barham (Institut Thématique Interdisciplinaire (ITI) de Médecine de Précision de Strasbourg, Strasbourg, France, France)
From HLA to MICA
09:00
Anat Tambur (Northwestern University, Feinberg School of Medicine, USA, United States)
HLA molecular matching to improve transplant outcomes.
09:30
Olga Timofeeva (MedStar Georgetown University Hospital, Washington D.C, USA, United States)
Guiding pre-transplant desensitization and post-transplant DSA treatment.
10:00-10:30Coffee Break

Coffee Break

10:30-12:00 Session 25A: Teaching Session: KIR immunogenetics & HLA epitopes

KIR immunogenetics & HLA epitopes: Mapping approaches & prediction methods

Chairs:
Eric Spierings (University Medical Center Utrecht, Netherlands)
Christelle Retière (Nantes Université, EFS, INSERM, CNRS, CRCI2NA, 44000, Nantes, France, France)
Location: Room 300
10:30
Christelle Retière (Nantes Université, EFS, INSERM, CNRS, CRCI2NA, 44000, Nantes, France, France)
KIR immunogenetics and NK cell diversity
11:00
Eric Spierings (HLA laboratory of the University Medical Center Utrecht, The Netherlands, Netherlands)
HLA epitopes and matching from a big data perspective
10:30-12:00 Session 25B: Special Joint EFI-SIP Session

Society for Immune Polymorphism: Advances in Clinical Immunogenomics

Chairs:
Martin Maiers (National Marrow Donor Program, United States)
Steven Mack (University of California, San Francisco, CA, United States., United States)
Paul Norman (University of Colorado, School of Medicine, Division of Biomedical Informatics and Personalized Medicine, Aurora, USA, United States)
10:30
Ami Bhatt (Departments of Medicine (Hematology & BMT) and Genetics | Stanford University, USA, United States)
From Precision Microbial Genomics to Precision Medicine.
11:00
Becca Asquith (Imperial college London, UK, UK)
KIRs, T cell dynamics, control of chronic virus infection and autoimmunity
11:30
Effie Pettersdorf (Madeline Dabney Adams Endowed Chair in AML Research, Fred Hutchinson Cancer Center, Seattle, USA, United States)
Immunogenetics of Hematopoietic Cell Transplantation
10:30-12:00 Session 25C: Abstract Session: Bioinformatics, data analysis in Immunogenetics (O41-O48)

Bioinformatics, data analysis in Immunogenetics

Chairs:
Neema P. Mayor (Anthony Nolan Research Institute, Royal Free Hospital, London, UK, UK)
Raphael Carapito (University of Strasbourg, France)
Location: Auditorium 450
10:30
Stephane Buhler (Geneva University Hospitals, Switzerland)
Zuleika Calderin Sollet (Geneva University Hospitals, Switzerland)
Florence Bettens (Geneva University Hospitals, Switzerland)
Antonia Schäfer (Geneva University Hospitals, Switzerland)
Marc Ansari (Geneva University Hospitals, Switzerland)
Sylvie Ferrari-Lacraz (Geneva University Hospitals, Switzerland)
Jean Villard (Geneva University Hospitals, Switzerland)
Unexposed individuals are fully equipped at the genetic level in terms of peptide coverage and T-cell repertoire against SARS-CoV-2: analysis in a cohort of healthy donors and alloHSCT recipients (abstract)
PRESENTER: Stephane Buhler
10:40
Erick Castelli (Unesp/Brazil, Brazil)
Eduardo Donadi (USP/Brazil, Brazil)
Celso Mendes-Junior (USP/Brazil, Brazil)
A new hla-mapper algorithm for alignment optimization of HLA sequences from RNA-seq (abstract)
PRESENTER: Erick Castelli
10:50
Léo Boussamet (CR2TI Nantes Université umr1064, France)
Augustin Moreau (CR2TI Nantes Université umr1064, France)
Justine Baron (CR2TI Nantes Université umr1064, France)
Sophie Limou (CR2TI Nantes Université umr1064, France)
Nicolas Vince (CR2TI Nantes Université umr1064, France)
HLA-3Diff: redefining donor-recipients HLA matching based on three dimensional structure prediction (abstract)
PRESENTER: Léo Boussamet
11:00
Juliano Boquett (University of California, San Francisco, United States)
Martin Maiers (National Marrow Donor Program/Be The Match, United States)
Jill Hollenbach (University of California, San Francisco, United States)
Human Leucocyte Antigen variation is associated with Cytomegalovirus seropositivity (abstract)
PRESENTER: Juliano Boquett
11:10
Nayane S. B. Silva (CR2TI - Nantes Université, France)
Venceslas Douillard (CR2TI - Nantes Université, France)
Viviane A. O. Ciriaco (São Paulo State University, Brazil)
Diogo Meyer (University of São Paulo, Brazil)
Michel Naslavsky (University of São Paulo, Brazil)
Yeda A. O. Duarte (University of São Paulo, Brazil)
Mayana Zatz (University of São Paulo, Brazil)
Pierre-Antoine Gourrand (CR2TI - Nantes Université, France)
Sophie Limou (CR2TI - Nantes Université, France)
Erick Castelli (São Paulo State University, Brazil)
Nicolas Vince (CR2TI, Nantes Université, France)
A large, improved and ancestry-diverse reference panel to impute HLA classical and non-classical class I alleles (abstract)
11:20
Stepan Nersisyan (Institute of Molecular Biology, National Academy of Sciences, Yerevan, Armenia, Armenia)
Anahit Hovhannisyan (Institute of Molecular Biology, National Academy of Sciences, Yerevan, Armenia, Armenia)
Armine Hyussyan (Armenian Bone Marrow Donor Registry Charitable Trust, Yerevan, Armenia, Armenia)
Siras Hakobyan (Institute of Molecular Biology, National Academy of Sciences, Yerevan, Armenia, Armenia)
Sevak Avagyan (Armenian Bone Marrow Donor Registry Charitable Trust, Yerevan, Armenia, Armenia)
Frieda Jordan (Armenian Bone Marrow Donor Registry Charitable Trust, Yerevan, Armenia, Armenia)
Arsen Arakelyan (Institute of Molecular Biology, National Academy of Sciences, Yerevan, Armenia, Armenia)
Karine Mayilyan (Institute of Molecular Biology, National Academy of Sciences, Yerevan, Armenia, Armenia)
Possible Biological Mechanisms Underlying the Association between COVID-19 Severity and HLA-C*04:01 (abstract)
PRESENTER: Frieda Jordan
11:30
Panagiotis Mallis (Immunology Department & National Tissue Typing Center, General Hospital of Athens "G. Gennimatas", Athens, Greece., Greece)
Alexandra Siorenta (Immunology Department & National Tissue Typing Center, General Hospital of Athens "G. Gennimatas", Athens, Greece., Greece)
Erasmia Stamathioudaki (Immunology Department & National Tissue Typing Center, General Hospital of Athens "G. Gennimatas", Athens, Greece., Greece)
Vasiliki Vrani (Immunology Department & National Tissue Typing Center, General Hospital of Athens "G. Gennimatas", Athens, Greece., Greece)
George Paterakis (Immunology Department & National Tissue Typing Center, General Hospital of Athens "G. Gennimatas", Athens, Greece., Greece)
The expanded role of microRNAs in controlling the HLA class I phenotype: Relationship between the 3’ UTR and post-transcriptional Gene Regulation (abstract)
11:40
Nickolai Alexandrov (One Lambda / ThermoFisher, United States)
Lindley Blair (One Lambda / Thermofisher, United States)
Ting Wang (One Lambda / Thermofisher, United States)
Brian Nadon (One Lambda / Thermofisher, United States)
David Sayer (One Lambda / ThermoFisher, Australia)
Analysis of "Big Data" reveals a new MHC Class I sequence, HLA-OLI, and the location of HLA-Y (abstract)
PRESENTER: Lindley Blair
10:30-12:00 Session 25D: Abstract Session: Immunotherapy, Gene Therapy, Cellular Therapy (O49-O56)

Immunotherapy, Gene Therapy, Cellular Therapy

Chairs:
Pietro Crivello (Institute for Experimental Cellular Therapy, University Hospital Essen, Germany)
Katia Gagne (Laboratoire de Recherche, Equipe 12 CRCI2NA, INSERM UMR1307, CNRS UMR 6075 EFS Centre-Pays de la Loire, France)
Location: Room 200
10:30
William Palmer (University of Colorado School of Medicine, United States)
Laura Ann Leaton (University of Colorado School of Medicine, United States)
Ana Compos Codo (University of Colorado School of Medicine, United States)
Bergren Crute (University of Colorado School of Medicine, United States)
Richard Tobin (University of Colorado School of Medicine, United States)
James Roest (Monash University, Australia)
Shiying Zhu (Monash University, Australia)
Jan Peterson (Monash University, Australia)
Patrick Hume (National Jewish Hospital Denver, United States)
William Janssen (National Jewish Hospital Denver, United States)
Matthew Stone (University of Colorado School of Medicine, United States)
Adrie Van Bokhoven (University of Colorado School of Medicine, United States)
Julian Vivian (Monash University, Australia)
Martin McCarter (University of Colorado School of Medicine, United States)
Andrew Getahun (University of Colorado School of Medicine, United States)
Jamie Rossjohn (Monash University, Australia)
John Trowsdale (University of Cambridge, UK)
John Cambier (University of Colorado School of Medicine, United States)
Liyen Loh (University of Colorado School of Medicine, United States)
Paul Norman (University of Colorado School of Medicine, United States)
Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells (abstract)
PRESENTER: Paul Norman
10:40
Kulvara Kittissares (Institute for Experimental Cellular Therapy, University Hospital Essen, Germany)
Pietro Crivello (Institute for Experimental Cellular Therapy, University Hospital Essen, Germany)
Thorben Walther (Institute for Experimental Cellular Therapy, University Hospital Essen, Germany)
Maryam Mohammaddokht (Institute of Neurophysiology, Charité Universitätsmedizin Berlin, Germany)
Thuja Arrieta Bolaños (Institute for Experimental Cellular Therapy, University Hospital Essen, Germany)
Maximilian F. Metzing (Institute for Experimental Cellular Therapy, University Hospital Essen, Germany)
Luisa Betke (Institute for Experimental Cellular Therapy, University Hospital Essen, Germany)
Dominik Lux (Medical Proteome Center, Center for Protein Diagnostics (PRODI), Ruhr University Bochum, Germany)
Thilo Bracht (Medical Proteome Center, Center for Protein Diagnostics (PRODI), Ruhr University Bochum, Germany)
Amin T. Turki (Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Germany)
Martin Eisenacher (Medical Proteome Center, Center for Protein Diagnostics (PRODI), Ruhr University Bochum, Germany)
Peter A. Horn (Institute for Transfusion Medicine, University Hospital Essen, Germany)
Johannes Köster (Algorithms for Reproducible Bioinformatics, Institute of Human Genetics, University Hospital Essen, Germany)
J. H. Frederik Falkenburg (Department of Hematology, Leiden University Medical Center, Netherlands)
Marieke Griffioen (Department of Hematology, Leiden University Medical Center, Netherlands)
Barbara Sitek (Medical Proteome Center, Center for Protein Diagnostics (PRODI), Ruhr University Bochum, Germany)
Katharina Fleischhauer (Institute for Experimental Cellular Therapy, University Hospital Essen, Germany)
Esteban Arrieta Bolaños (Institute for Experimental Cellular Therapy, University Hospital Essen, Germany)
Memory CD4+ T cells efficiently recognize divergent HLA-DP immunopeptidomes relevant in allogeneic hematopoietic cell transplantation (abstract)
10:50
Maria Michela Santamorena (Hannover Medical School, Germany)
Agnes Bonifacius (Hannover Medical School, Germany)
Noemi Mireisz (University of Würzburg, Germany)
Luise Krajewski (TWINCORE, Germany)
Jennifer Becker (TWINCORE, Germany)
Alice Rein (University Hospital Würzburg, Germany)
Sabrina Kraus (University Hospital Würzburg, Germany)
Britta Maecker-Kolhoff (Hannover Medical School, Germany)
Renata Stripecke (Hannover Medical School, Germany)
Rainer Blasczyk (Hannover Medical School, Germany)
Andreas Schlosser (University of Würzburg, Germany)
Ulrich Kalinke (TWINCORE, Germany)
Sabine Tischer-Zimmermann (Hannover Medical School, Germany)
Britta Eiz-Vesper (Hannover Medical School, Germany)
Discovery of the human cytomegalovirus-specific peptide repertoire naturally processed and presented by infected human antigen presenting cells (abstract)
11:00
Pietro Crivello (Institute for Experimental Cellular Therapy, University Hospital Essen, Germany)
Thilo Bracht (Medical Proteome Center, Center for Protein Diagnostics, Ruhr University Bochum, Germany)
Dominik Lux (Medical Proteome Center, Center for Protein Diagnostics, Ruhr University Bochum, Germany)
Joana Peters (Institute for Experimental Cellular Therapy, University Hospital Essen, Germany)
Sophia Layer (Institute for Experimental Cellular Therapy, University Hospital Essen, Germany)
Malte Bayer (Medical Proteome Center, Center for Protein Diagnostics, Ruhr University Bochum, Germany)
Marie S. Eppler (Institute for Experimental Cellular Therapy, University Hospital Essen, Germany)
Martin Eisenacher (Medical Proteome Center, Center for Protein Diagnostics, Ruhr University Bochum, Germany)
Barbara Sitek (Medical Proteome Center, Center for Protein Diagnostics, Ruhr University Bochum, Germany)
Katharina Fleischhauer (Institute for Experimental Cellular Therapy, University Hospital Essen, Germany)
Exploring the cryptic HLA-DP immunopeptidome for new targets of T cell immunotherapy in acute myeloid leukemia (abstract)
PRESENTER: Pietro Crivello
11:10
Meenakshi Singh (ACTREC, Tata Memorial Centre, India)
Bhanu Prakash Kota (ACTREC,Tata Memorial Centre, India)
Omkar Bhosale (ACTREC,Tata Memorial Centre, India)
Akansha Chichra (ACTREC,Tata Memorial Centre, India)
Nishant Jindal (ACTREC,Tata Memorial Centre, India)
Sachin Punatar (ACTREC,Tata Memorial Centre, India)
Anant Gokarn (ACTREC,Tata Memorial Centre, India)
Sumeet Mirgh (ACTREC,Tata Memorial Centre, India)
Selma D'Silva (ACTREC,Tata Memorial Centre, India)
Navin Khattry (ACTREC,Tata Memorial Centre, India)
Generation and Characterization of third party donor derived AdV, CMV and EBV multivirus specific T cells for therapeutic intervention in patients undergoing Hematopoietic Stem Cell Transplantation (abstract)
PRESENTER: Meenakshi Singh
11:20
Sapir Israeli (Bar ILan University, Israel)
Elizabeth Krakow (Hutchison cancer center, United States)
Martin Maiers (National Marrow Donor Program, United States)
Corrine Summers (Hutchison cancer center, United States)
Yoram Louzoun (Bar Ilan University, Israel)
Optimal population coverage for cellular therapies (abstract)
PRESENTER: Yoram Louzoun
11:30
Samuel Bruce (Clinical Immunology, PathWest, Fiona Stanley Hospital, Perth, Australia, Australia)
Linh Truong (Clinical Immunology, PathWest, Fiona Stanley Hospital, Perth, Australia, Australia)
Jonathan Downing (Clinical Immunology, PathWest, Fiona Stanley Hospital, Perth, Australia, Australia)
Dianne De Santis (Clinical Immunology, PathWest, Fiona Stanley Hospital, Perth, Australia, Australia)
Patricia Martinez (Clinical Immunology, PathWest, Fiona Stanley Hospital, Perth, Australia, Australia)
Lloyd D'Orsogna (Clinical Immunology, PathWest, Fiona Stanley Hospital, Perth, Australia, Australia)
THE STIMULATION OF MEMORY B CELLS FOR THE IDENTIFICATION OF UNACCEPTABLE ANTIGENS IN SOLID ORGAN TRANSPLANTATION (abstract)
PRESENTER: Linh Truong
11:40
Emmanuelle Rial-Sebbag (CERPOP, Inserm, France)
Anne Cambon-Thomsen (CNRS, France)
Anne-Marie Duguet (Université Paul Sabatier, UT3, France)
New regulatory dimensions for transplantation, genetics and stem cell research in the French bioethics law. Consequences for European collaborations. (abstract)
12:00-12:10Coffee Break

Coffee Break 

12:00-14:00 Session 26: SIP Board meeting

SIP Board meeting

Chairs:
Martin Maiers (National Marrow Donor Program, United States)
Steven Mack (University of California, San Francisco, CA, United States., United States)
Location: Room J
12:10-13:10 Session 27: Luncheon Industry symposium: GenDx

Luncheon Industry symposium: GenDx

Location: Room 300
13:20-14:20 Session 28: Luncheon Industry symposium: One Lambda Inc. A Thermo Fisher Scientific Brand

Luncheon Industry symposium: One Lambda Inc. A Thermo Fisher Scientific Brand

Location: Room 300
13:30-14:30 Session 29: EBTI GA

EBTI GA

Chair:
David Turner (Scottish National Blood Transfusion Service, Royal Infirmary Edinburgh, UK)
Location: Room G
14:30-16:00 Session 30A: Teaching Session: Bioinformatics for Research Application

Bioinformatics for Research Application: Haplotype and Population Structure Inference using AI

Chairs:
Yang Luo (University of Oxford, UK)
Jean-Baptiste Woillard (Pharmacology, Toxicology Department, CHU Limoges/ INSERM U1248, University of Limoges, Limoges, France, France)
Mathijs Groeneweg (Maastricht University Medical Centre, Netherlands)
Location: Room 300
14:30
Yang Luo (The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK, UK)
Pinpointing HLA selection signal in admixed populations
15:00
Jean-Baptiste Woillard (Pharmacology, Toxicology Department, CHU Limoges/ INSERM U1248, University of Limoges, Limoges, France, France)
Application of machine learning to prediction of immunosuppressant exposure, the example of tacrolimus
14:30-16:00 Session 30B: Meet the Experts & Young EFI Group

Meet the expert & Young EFI

Chairs:
Dominique Charron (Chef de Service Honoraire, Laboratoire "Jean Dausset" AP-HP, Hopital Saint-Louis,Paris, France, France)
Arianne Brandsma (Immunogenetics department, Sanquin Diagnostiek B.V, Netherlands, Netherlands)
Steven Marsh (Anthony Nolan Research Institute, Cancer Institute, University College London, London, UK, UK)
Timo Olieslagers (Transplantation Immunology, Tissue Typing Laboratory, Maastricht University Medical Center, Maastricht, the Netherlands, Netherlands)
Katharina Fleischhauer (University Hospital Essen, Germany)
14:30-16:00 Session 30C: Abstract Session: Hematopoietic Stem Cell Transplantation (O57-O64)

Hematopoietic Stem Cell Transplantation (HSCT)

Chairs:
Valérie Dubois (EFS Auvergne-Rhône-Alpes, Décine-Charpieu, France)
Antonij Slavčev (Institute for Clinical and Experimental Medicine, Prague, Czechia)
Location: Auditorium 450
14:30
Esteban Arrieta Bolaños (Institute for Experimental Cellular Therapy, University Hospital Essen, Germany)
Lars L. J. van der Burg (Department of Biomedical Data Sciences, LUMC, Netherlands)
Tobias Gedde-Dahl (Oslo University Hospital, Rikshospitalet, Norway)
Marie Robin (Saint-Louis Hospital, BMT Unit, France)
Urpu Salmenniemi (HUCH Comprehensive Cancer Center, Finland)
Nicolaus Kröger (University Hospital Eppendorf, Germany)
Ibrahim Yakoub-Agha (CHU de Lille, France)
Anne Huynh (CHU - Institut Universitaire du Cancer Toulouse, France)
Charles Crawley (Addenbrookes Hospital, UK)
Eric Deconinck (Hopital Jean Minjoz, France)
Claude Eric Bulabois (CHU Grenoble Alpes - Université Grenoble Alpes, France)
Edouard Forcade (CHU Bordeaux,, France)
Eleni Tholouli (Manchester Royal Infirmary, UK)
Jorinde D. Hoogenboom (EBMT Leiden Study Unit, Netherlands)
Joost G. K. van der Hem (Department of Hematology, LUMC, Netherlands)
Peter van Balen (Department of Hematology, LUMC, Netherlands)
Liesbeth C. de Wreede (Department of Biomedical Data Sciences, LUMC, Netherlands)
Florent Malard (Hopital Saint Antoine, France)
Annalisa Ruggeri (San Raffaele Scientific Institute, Hematology and Bone marrow Transplantation unit, Italy)
Katharina Fleischhauer (Institute for Experimental Cellular Therapy, University Hospital Essen, Germany)
HLA-DP permissive mismatch subsets confer reduced aGvHD risks and improved disease control after hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes (abstract)
14:40
Carlotta Welters (Charité Universitätsmedizin Berlin, Germany)
Marthe-Lina Welters (Charité Universitätsmedizin Berlin, Germany)
Serena Stadler (German Cancer Consortium (DKTK), Partner Site Berlin, Germany)
Arunraj Dhamodaran (T-Knife, United States)
Lars Bullinger (Charité Universitätsmedizin Berlin, Germany)
Thomas Blankenstein (Molecular Immunology and Gene Therapy, Max-Delbrück-Center for Molecular Medicine (MDC), Berlin, Germany)
Leo Hansmann (Charité Universitätsmedizin Berlin, Germany)
T cells can be activated by epitopes presented on HLA-C*04:09N (abstract)
PRESENTER: Carlotta Welters
14:50
Antonia Schäfer (Geneva University Hospitals, Geneva, Switzerland)
Zuleika Calderin Sollet (Geneva University Hospitals, Geneva, Switzerland)
Stephane Buhler (Geneva University Hospitals, Geneva, Switzerland)
Sylvie Ferrari-Lacraz (Geneva University Hospitals, Geneva, Switzerland)
Stavroula Masouridi-Levrat (Geneva University Hospitals, Geneva, Switzerland)
Anne-Claire Mamez (Geneva University Hospitals, Geneva, Switzerland)
Yves Chalandon (Geneva University Hospitals, Geneva, Switzerland)
Jean Villard (Geneva University Hospitals, Geneva, Switzerland)
Longitudinal tracking of T – cell receptor repertoire reconstitution after allogeneic hematopoietic stem cell transplantation (abstract)
PRESENTER: Antonia Schäfer
15:00
Pietro Crivello (Institute for experimental Cellular Therapy, University Hospital Essen, Germany)
Jarl E. Mooyaart (EBMT Statistical Unit, Leiden, Netherlands)
Nicolaus Kröger (University Hospital Eppendorf, Hamburg,, Germany)
Régis Peffault de Latour (Saint-Louis Hospital, BMT Unit, Paris, France)
Henrik Sengeloev (Bone Marrow Transplant Unit L 4043, Copenhagen, Denmark)
Ibrahim Yakoub-Agha (CHU de Lille, Lille, France)
Jürgen Finke (University of Freiburg, Freiburg, Germany)
Wolfgang Bethge (Universitaet Tuebingen, Tuebingen, Germany)
Peter Dreger (University of Heidelberg, Heidelberg, Germany)
Victoria Potter (Kings College Hospital, London, UK)
David Burns (University Hospital Birmingham NHSTrust, Stoke, UK)
Tobias Gedde-Dahl (Oslo University Hospital, Rikshospitalet, Oslo, Norway)
Anne Huynh (CHU - Institut Universitaire du Cancer Toulouse, Toulouse, France)
Stephan Mielke (Karolinska University Hospital, Stockholm, Sweden)
Matthias Eder (Hannover Medical School, Hannover, Germany)
Claude Eric Bulabois (CHU Grenoble Alpes - Université Grenoble Alpes, Grenoble, France)
Edouard Forcade (CHU Bordeaux, Pessac, France)
A.E.C. Broers (Erasmus MC Cancer Institute, Rotterdam, Netherlands)
Urpu Salmenniemi (HUCH Comprehensive Cancer Center, Helsinki, Finland)
Inken Hilgendorf (Universitaetsklinikum Jena, Jena, Germany)
Goda Choi (University Medical Center Groningen (UMCG), Groningen, Netherlands)
Jenny Byrne (Nottingham University, Nottingham, UK)
Kim Orchard (Southampton General Hospital, Southampton, UK)
Virginie Gandemer (Centre Hospitalier Universitaire de Rennes, Rennes, France)
Eric Deconinck (Hopital Jean Minjoz, Besancon, France)
Pietro Merli (IRRCS Ospedale Pediatrico Bambino Gesù, Rome, Italy)
Marco Andreani (IRRCS Ospedale Pediatrico Bambino Gesù, Rome, Italy)
Simona Pagliuca (Service d'hématologie Clinique, Hôpital Brabois, Biopole de l'Université de Loarraine, Vandoeuvre les Nancy, France)
Carmelo Gurnari (Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy)
Jorinde D. Hoogenboom (EBMT Leiden Study Unit, Leiden, Netherlands)
Liesbeth C. de Wreede (Department of Biomedical Data Sciences, LUMC, Leiden, Netherlands)
Tobias Lenz (Research Unit for Evolutionary Immunogenomics, Department of Biology, University of Hamburg, Germany)
Christian Chabannon (Institut Paoli-Calmettes, Marseille, France)
Annalisa Ruggeri (San Raffaele Scientific Institute, Hematology and Bone marrow Transplantation Unit, Milan, Italy)
Katharina Fleischhauer (Institute for Experimental Cellular Therapy, University Hospital Essen, Germany)
Associations between HLA Evolutionary Divergence and clinical outcome of matched related or unrelated stem cell transplantation: a study from the EBMT Cellular Therapy and Immunobiology Working Party (abstract)
PRESENTER: Pietro Crivello
15:10
Rosalia Cacciatore (IRCCS Policlinico Sana Matteo, Pavia, Italy)
Annamaria Pasi (IRCCS Policlinico San Matteo Pavia, Italy)
Paola Bergamaschi (IRCCS Policlinico San Matteo, Pavia, Italy)
Giovanna Giorgiani (IRCCS Policlinico San Matteo, Pavia, Italy)
Daniela Caldera (IRCCS Policlinico San Matteo, Pavia, Italy)
Patrizia Comoli (IRCCS Policlinico San Matteo, Pavia, Italy)
Anna Amelia Colombo (IRCCS Policlinico San Matteo, Pavia, Italy)
Ilaria Sbarsi (IRCCS Policlinico San Matteo, Pavia, Italy)
Lorenza Chiesa (IRCCS Policlinico San Matteo, Pavia, Italy)
Daniela Troletti (IRCCS Policlinico San Matteo, Pavia, Italy)
Elena Cornella (IRCCS Policlinico San Matteo, Pavia, Italy)
Martin Hoffmann (IRCCS Policlinico San Matteo, Pavia, Italy)
Maria Cristina Monti (IRCCS Policlinico San Matteo, Pavia, Italy)
Cesare Perotti (IRCCS Policlinico San Matteo, Pavia, Italy)
Paolo Bernasconi (IRCCS Policlinico San Matteo, Pavia, Italy)
Luca Arcaini (IRCCS Policlinico San Matteo, Pavia, Italy)
Marco Zecca (IRCCS Policlinico San Matteo, Pavia, Italy)
The role of Recipient Specific Antibodies (RSA) in transplant outcome. Analysis of a group of family donors selected for patients undergoing haploidentical transplantation. (abstract)
PRESENTER: Annamaria Pasi
15:20
Debora Jorge Cordeiro (Saint Louis Hospital, APHP, PARIS, France)
Juliette Villemonteix (Saint Louis Hospital, APHP, PARIS, France)
Alienor Xhaard (Saint Louis Hospital, APHP, PARIS, France)
Ophélie Ferrary (Saint Louis Hospital, APHP, PARIS, France)
Bruno A. Lima (Oficina de Bioestistica, Ermesinde, Portugal)
Vincent Allain (Saint Louis Hospital, APHP, PARIS, France)
Sophie Caillat-Zucman (Saint Louis Hospital, APHP, PARIS, France)
HLA evolutionary divergence (HED) influences the outcome of haploidentical hematopoietic stem cell transplantation in adult patients with hematological malignancies. (abstract)
15:30
Sapir Israeli (Bar ILan University, Israel)
Martin Maiers (National Marrow Donor Program, United States)
Loren Gragert (Tulane University School of Medicine, United States)
Joel Schneider (NMDP, United States)
Abeer Madbouly (NMDP, United States)
Pradeep Bayshal (NMDP, United States)
Yoram Louzoun (Bar Ilan University, Israel)
Combined imputation of HLA genotype and race leads to better donor-recipient matching (abstract)
PRESENTER: Yoram Louzoun
15:40
Heloísa S Andrade (Laboratory of Evolutionary Genetics, Institute of Biosciences, University of São Paulo, São Paulo, Brazil, Brazil)
Márcio Silva (Instituto de Matemática e Estatística, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil, Brazil)
Kelly Nunes (Laboratory of Evolutionary Genetics, Institute of Biosciences, University of São Paulo, São Paulo, Brazil, Brazil)
Carlos Henrique Passos (Laboratory of Evolutionary Genetics, Institute of Biosciences, University of São Paulo, São Paulo, Brazil, Brazil)
Alexandre C. Sena (Instituto de Matemática e Estatística, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil, Brazil)
Erick C. Castelli (Molecular Genetics and Bioinformatics Laboratory, Experimental Research Unity, School of Medicine, UNESP, Brazil)
Carla Dinardo (Fundação Pró Sangue, Hemocentro de São Paulo, São Paulo, Brazil, Brazil)
Ester C. Sabino (Instituto de Medicina Tropical, Departamento de Moléstias Infecciosas e Parasitárias da Faculdade de Medicina da USP, Brazil)
Carolina M. Teixeira (Fundação Hemominas, Minas Gerais, Brazil, Brazil)
Dahra Teles (Fundação de Hematologia e Hemoterapia de Pernambuco (Hemope), Recife, Brazil, Brazil)
Luiz Amorim (Instituto de Hematologia Arthur de Siqueira Cavalcanti (HEMORIO), Rio de Janeiro, Brazil, Brazil)
Brian Custer (Epidemiology, Vitalant Research Institute, San Francisco, CA, United States, United States)
Shannon Kelly (Epidemiology, Vitalant Research Institute, San Francisco, CA, United States, United States)
Luís Cristóvão Pôrto (Laboratório de Histocompatibilidade e Criopreservação, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil, Brazil)
Diogo Meyer (Laboratory of Evolutionary Genetics, Institute of Biosciences, University of São Paulo, São Paulo, Brazil, Brazil)
Genetic variation in HLA genes: impact on transplant compatibility in a Brazilian admixed population (abstract)
14:30-16:00 Session 30D: Abstract Session: Autoimmunity, Infection, Reproduction & Cancer (O65-O72)

Autoimmunity, Infection, Reproduction & Cancer

Chairs:
Jill Hollenbach (University of California San Francisco, USA, United States)
Régis Josien (Nantes Université, CHU Nantes, INSERM, CR2TI UMR 1064, Nantes, France, France)
Location: Room 200
14:30
Stefano Mocci (Medical Genetics Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy., Italy)
Roberto Littera (Medical Genetics Unit, R. Binaghi Hospital, Local Public Health and Social Care Unit of Cagliari, Cagliari, Italy., Italy)
Stefania Tranquilli (Medical Genetics Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy., Italy)
Federica Cannas (Medical Genetics Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy., Italy)
Michela Lorrai (Medical Genetics Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy., Italy)
Alessia Mascia (Medical Genetics Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy., Italy)
Caterina Mereu (Medical Genetics Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy., Italy)
Celeste Sanna (Medical Genetics Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy., Italy)
Sara Lai (Medical Genetics Unit, R. Binaghi Hospital, Local Public Health and Social Care Unit of Cagliari, Cagliari, Italy., Italy)
Erika Giuressi (Medical Genetics Unit, R. Binaghi Hospital, Local Public Health and Social Care Unit of Cagliari, Cagliari, Italy., Italy)
Sabrina Giglio (Medical Genetics Unit, R. Binaghi Hospital, Local Public Health and Social Care Unit of Cagliari, Cagliari, Italy., Italy)
A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited from Neanderthals in the Sardinian Population. (abstract)
PRESENTER: Stefano Mocci
14:40
Roberto Crocchiolo (ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy)
Coralie Frassati (Laboratoire HLA, EFS PACA-Corse, Marseille, France)
Anna Maria Gallina (Italian Bone Marrow Donor Registry, Genova, Italy)
Pascal Pedini (Laboratoire HLA, EFS PACA-Corse, Marseille, France)
Sandrine Maioli (Laboratoire HLA, EFS PACA-Corse, Marseille, France)
Arianna Pani (ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy)
Francesco Scaglione (ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy)
Nicoletta Sacchi (Italian Bone Marrow Donor Registry, Genova, Italy)
Silvano Rossini (ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy)
Christophe Picard (Laboratoire HLA, EFS PACA-Corse, Marseille, France)
HLA-A*03:01 significantly predicts strong humoral response at six months after mRNA vaccination: results from the observational prospective cohort study RENAISSANCE (abstract)
14:50
Martin Morin (Nantes Université, CHU Nantes, Centrale Nantes, Inserm, CR2TI, UMR1064, France)
Cheryl Winkler (Basic Science Program, Leidos Biomedical Research, Inc., Frederick National Laboratory, United States)
Hermann Bussmann (Harvard School of Public Health, Department of Immunology and Infectious Diseases, United States)
Vladimir Novitsky (Harvard School of Public Health, Department of Immunology and Infectious Diseases, United States)
Sikhulile Moyo (Botswana-Harvard School of Public Health AIDS Initiative Partnership for HIV Research and Education (BHP), Botswana)
Max Essex (Harvard School of Public Health, Department of Immunology and Infectious Diseases, United States)
Richard Marlink (Harvard School of Public Health, Department of Immunology and Infectious Diseases, United States)
William Wester (Harvard School of Public Health, Department of Immunology and Infectious Diseases, United States)
Sophie Limou (Nantes Université, CHU Nantes, Centrale Nantes, Inserm, CR2TI, UMR1064, France)
NEGR1 genetic variants and risk for virological failure in the HIV-positive Botswanian population (abstract)
PRESENTER: Martin Morin
15:00
Jacqueline Williams (UCSF, United States)
Danillo Augusto (UNCC, United States)
Wesley Marin (UCSF, United States)
Kerry Kizer (UCSF, United States)
Kristen J. Wade (UCSF, United States)
Stacy Caillier (UCSF, United States)
Jorge Oksenberg (UCSF, United States)
Jill Hollenbach (UCSF, United States)
Copy number variation of the C4L gene isoform is associated with risk for multiple sclerosis” (abstract)
15:10
Ritu Aggarwal (Postgraduate Institute of Medical Education and Research, Chandigarh, India)
Navdeep Mangat (Postgraduate Institute of Medical Education and Research, Chandigarh, India)
Tanvi Bhatia (Postgraduate Institute of Medical Education and Research, Chandigarh, India)
Madhulika Sharma (Postgraduate Institute of Medical Education and Research, Chandigarh, India)
Jasleen Kaur (Postgraduate Institute of Medical Education and Research, Chandigarh, India)
Vanita Suri (Postgraduate Institute of Medical Education and Research, Chandigarh, India)
Ranjana Minz (Postgraduate Institute of Medical Education and Research, Chandigarh, India)
To study the HLA-E expression in HPV infected Cervical Carcinoma (abstract)
PRESENTER: Ritu Aggarwal
15:20
Gil Benedek (Hadassah-Hebrew University Medical Center, Jerusalem, Israel, Israel)
Aviran Aharon (Hebrew University-Hadassah Faculty of Medicine, Jerusalem, Israel, Israel)
Barhoum Barhoum (Hadassah-Hebrew University Medical Center, Jerusalem, Israel, Israel)
Elchanan Parnasa (Hadassah-Hebrew University Medical Center, Jerusalem, Israel, Israel)
Nur Magadle (Hadassah-Hebrew University Medical Center, Jerusalem, Israel, Israel)
Ofer Perzon (Hadassah-Hebrew University Medical Center, Jerusalem, Israel, Israel)
Dror Mevorach (Hadassah-Hebrew University Medical Center, Jerusalem, Israel, Israel)
HLA binding-groove motifs are associated with myocarditis induction after Pfizer-BioNTech BNT162b2 vaccination (abstract)
PRESENTER: Gil Benedek
15:30
Kerry Kizer (University of California San Francisco, United States)
Danillo Augusto (University of North Carolina at Charlotte, United States)
Gonzalo Montero-Martin (Stanford University, United States)
Noelle Schlenk (Stanford University, United States)
Jacquelyn Horgan (Stanford University, United States)
Kristen Wade (University of California San Francisco, United States)
Jorge Oksenberg (University of California San Francisco, United States)
Marcelo Fernandez-Vina (Stanford University, United States)
Jennifer Frankovich (Stanford University, United States)
Jill Hollenbach (University of California San Francisco, United States)
HLA-Bw4 is Associated with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) (abstract)
PRESENTER: Kerry Kizer
15:40
Stephanie Gras (La Trobe University, Australia)
Fight against COVID-19: functional and structural study of the T cell response​ (abstract)
16:00-16:30Coffee Break

Coffee Break 

16:30-18:00 Session 31: Plenary Session IV

AI & Big data transforming medical research

Chairs:
Sophie Limou (Center for Research in Transplantation and Translational Immunology (CR2TI), France)
James Robinson (Anthony Nolan Research Institute, UK)
16:30
Soumya Raychaudhuri ((1) Brigham and Women’s Hospital, (2) Harvard Medical School, and (3) Broad Institute, USA, France)
Fine-mapping complex loci for autoimmune diseases
17:00
Marta Alarcón-Riquelme (Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government, Spain, Spain)
Using transcriptome data to stratify and predict treatment responses in lupus and other systemic autoimmune diseases.
17:30
Patrick Deelen (Department of Genetics, University Medical Center Groningen, Groningen, the Netherlands, Netherlands)
Using tissue and cell type-specific gene regulatory networks to predict driver genes of common diseases.
18:00-19:30 Session 32: EFI GENERAL ASSEMBLY

EFI GENERAL ASSEMBLY

Chair:
Ann-Margaret Little (Histocompatibility and Immunogenetics, Laboratory Medicine, Gartnavel General Hospital, Glasgow, UK, UK)
Saturday, April 29th

View this program: with abstractssession overviewtalk overview

08:30-10:00 Session 33: Best Abstract Session (O1-O9)

Best Abstract Session

Chairs:
Luca Vago (IRCCS San Raffaele Scientific Institute, Italy)
Ann-Margaret Little (Histocompatibility and Immunogenetics, Laboratory Medicine, Gartnavel General Hospital, Glasgow, UK, UK)
08:30
Michel Kester (Department of Hematology, Leiden University Medical Center, Netherlands)
Sebastian Klobuch (Department of Hematology, Leiden University Medical Center, Netherlands)
Peter van Balen (Department of Hematology, Leiden University Medical Center, Netherlands)
Wendy de Klerk (Department of Hematology, Leiden University Medical Center, Netherlands)
Arnoud de Ru (Center for Proteomics and Metabolomics, Leiden University Medical Center, Netherlands)
Inge Jedema (Department of Hematology, Leiden University Medical Center, Netherlands)
Peter van Veelen (Center for Proteomics and Metabolomics, Leiden University Medical Center, Netherlands)
J. H. Frederik Falkenburg (Department of Hematology, Leiden University Medical Center, Netherlands)
Mirjam H. M. Heemskerk (Department of Hematology, Leiden University Medical Center, Netherlands)
Forward or reversed binding of peptides within the HLA-DP peptidome is mainly determined by the HLA-DPB1 allele but with a key role for the HLA-DPA1 chain. (abstract)
PRESENTER: Michel Kester
08:40
Pier Edoardo Rovatti (Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milano, Italy)
Marco Punta (Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milano, Italy)
Matteo Maria Naldini (Translational Stem Cell and Leukemia Unit, San Raffaele TIGET, IRCCS San Raffaele Scientific Institute, Milano, Italy)
Laura Zito (Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milano, Italy)
Matteo Giovanni Carrabba (Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy)
Massimo Bernardi (Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy)
Peccatori Jacopo (Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy)
Ivan Merelli (Institute for Biomedical Technologies, National Research Council, Segrate, Italy)
Bernhard Gentner (Translational Stem Cell and Leukemia Unit, San Raffaele TIGET, IRCCS San Raffaele Scientific Institute, Milano, Italy)
Fabio Ciceri (Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy)
Luca Vago (Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milano, Italy)
Cristina Toffalori (Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milano, Italy)
Single cell transcriptomics to identify leukemia-intrinsic and -extrinsic bone marrow correlates of immune escape and post-transplantation relapse (abstract)
PRESENTER: Marco Punta
08:50
Philip Mausberg (Hannover Medical School, Germany)
Anna Christina Dragon (Hannover Medical School, Germany)
Stefanie Thölke (Hannover Medical School, Germany)
María Fernanda Lammoglia Cobo (Charité-Universitätsmedizin Berlin, Germany)
Sven Stoll (Hannover Medical School, Germany)
Sabine Tischer-Zimmermann (Hannover Medicla School, Germany)
Rainer Blasczyk (Hannover Medical School, Germany)
Michael Hudecek (University of Würzburg, Germany)
Axel Schambach (Hannover Medical School, Germany)
Leo Hansmann (Charité-Universitätsmedizin Berlin, Germany)
Britta Maecker-Kolhoff (Hannover Medical School, Germany)
Agnes Bonifacius (Hannover Medical School, Germany)
Britta Eiz-Vesper (Hannover Medical School, Germany)
Highly specific Latent Membrane Protein 2A-targeting T-Cell Receptor-engineered T cells with inducible Interleukin-18 expression as promising tool to treat Epstein-Barr Virus-associated malignancies (abstract)
PRESENTER: Philip Mausberg
09:00
Funmilola Josephine Haukamp (Hanover Medical School, Germany)
Zoe Maria Hartmann (Hanover Medical School, Germany)
Andreas Pich (Hanover Medical School, Germany)
Joachim Kuhn (Heart and Diabetes Center North Rhine-Westphalia, Germany)
Rainer Blasczyk (Hanover Medical School, Germany)
Florian Stieglitz (Hanover Medical School, Germany)
Christina Bade-Doeding (Hanover Medical School, Germany)
Proteome analysis of drug susceptible HLA-B*57:01+ cells reveals the pivotal mechanisms of HLA-mediated Carbamazepine hypersensitivity (abstract)
09:10
Kathryn Hussey (University of Southampton, UK)
Ella Milne (University of Southampton, UK)
Rodrigo Hamede (University of Tasmania, Australia)
Hannah Siddle (University of Southampton, UK)
The evolution of MHC class I loss in a newly emerged transmissible cancer in Tasmanian devils (abstract)
PRESENTER: Kathryn Hussey
09:20
Reut Levi (Bar Ilan University, Israel)
Lee Levi (Bar Ilan University, Israel)
Yoram Louzoun (Bar Ilan University, Israel)
Bw4 ligand and direct T-cell receptor binding induced selection on HLA A and B alleles (abstract)
PRESENTER: Yoram Louzoun
09:30
Cynthia Kramer (Dept. Immunology, Leiden University Medical Center, Netherlands)
Ben Matern (Center of Translational Immunology, UMC Utrecht, Netherlands)
Geert Haasnoot (Dept. Immunology, Leiden University Medical Center, Netherlands)
Paul Dunn (Transplant Laboratory, University Hospitals of Leicester NHS Trust, UK)
Duangtawan Thammanichanond (Dept. of Pathology, Faculty of Medice Ramathibodi Hospital, Thailand)
Wendy Swelsen (Immunogenetics, Sanquin diagnostic Services, Netherlands)
Antonij Slavcev (Dept. of Immunogenetics, IKEM, Czechia)
Blanka Vidan-Jeras (Tissue Typing Center, Blood Transfusion Center of Solvenia, Slovenia)
Martin Barnardo (Transplant Immunology, Oxford University Hospitals, UK)
Beatrice Bardy (HLA, Etablissement Français du Sang, France)
Gottfried Fischer (Dept for Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Austria)
Renata Zunec (Clinical Dept. of Transfusion and Transplantation Biology, University Hospital Zagreb, Croatia)
Dave Roelen (Dept. Immunology, Leiden University Medical Center, Netherlands)
Frans Claas (Dept. Immunology, Leiden University Medical Center, Netherlands)
Eric Spierings (Center of Translational Immunology, UMC Utrecht, Netherlands)
Sebastiaan Heidt (Dept. Immunology, Leiden University Medical Center, Netherlands)
The 18th International HLA and Immunogenetics Workshop (IHIWS) HLA immunogenic epitope project (abstract)
PRESENTER: Cynthia Kramer
09:40
Xuezi Tian (Department of Obstetrics and Gynecology, Leiden University Medical Center, Leiden, the Netherlands, Netherlands)
Juliette Krop (Department of Immunology, Leiden University Medical Center, Leiden, Netherlands, Netherlands)
Marieke E. Ijsselsteijn (Department of Pathology, Leiden University Medical Center, Leiden, Netherlands, Netherlands)
Hanneke Kapsenberg (Department of Immunology, Leiden University Medical Center, Leiden, Netherlands, Netherlands)
Carin van der Keur (Department of Immunology, Leiden University Medical Center, Leiden, Netherlands, Netherlands)
Lisa E.E.L.O. Lashley (Department of Gynecology and Obstetrics, Leiden University Medical Center, Leiden, Netherlands, Netherlands)
Dave L. Roelen (Department of Immunology, Leiden University Medical Center, Leiden, Netherlands, Netherlands)
Noel F.C.C. de Miranda (Department of Pathology, Leiden University Medical Center, Leiden, Netherlands, Netherlands)
Frits Koning (Department of Immunology, Leiden University Medical Center, Leiden, Netherlands, Netherlands)
Marie-Louise P. van der Hoorn (Department of Gynecology and Obstetrics, Leiden University Medical Center, Leiden, Netherlands, Netherlands)
Michael Eikmans (Department of Immunology, Leiden University Medical Center, Leiden, Netherlands, Netherlands)
Spatial composition of decidual immune cells in oocyte donation pregnancies in relation to fetal-maternal HLA incompatibility (abstract)
PRESENTER: Xuezi Tian
10:00-10:30Coffee Break

Coffee Break 

10:30-12:00 Session 34: Plenary Session V

Autoimmune diseases & Infections

Chairs:
Nicolas Vince (Nantes Université, CR2TI UMR1064, Nantes, France, France)
John Trowsdale (Cambridge University, UK)
10:30
Marco Salvetti (Department of Neurosciences, NESMOS, Neurology Residency Program, Sapienza University, Italy, Italy)
Infectious cause & Immunology of MS.
11:00
Hedda Wardemann (Division B Cell Immunology, German Cancer Research Center (DKFZ), Foundation under Public Law, Germany, Germany)
Repertoire profiling of adaptive immune responses against the human malaria parasite Plasmodium falciparum.
11:30
Darragh Duffy (Institut Pasteur Paris, France, France)
Understanding immune diversity in health and disease.
12:00-13:30 Session 35: Closing Ceremony

Closing Ceremony 

Chairs:
Pierre-Antoine Gourraud (Nantes Université, CR2TI UMR1064, Nantes, France, France)
Ann-Margaret Little (Histocompatibility and Immunogenetics, Laboratory Medicine, Gartnavel General Hospital, Glasgow, UK, UK)
12:00
Fridolin Gross (CNRS UMR 5164 – Bordeaux University, France)
Towards systems immunology? A philosophical perspective on the challenges of integrating Big Data and modeling
12:30
Sebastiaan Heidt (LUMC, Netherlands)
IHIWS +365 Report
13:00
Steven Marsh (Anthony Nolan Research Institute, Cancer Institute, University College London, London, UK, UK)
Jon Van Rood Award & Best Abstract Awards
13:15
Steven Marsh (Anthony Nolan Research Institute, Cancer Institute, University College London, London, UK, UK)
Best Poster Awards
13:30
Ann-Margaret Little (Histocompatibility and Immunogenetics, Laboratory Medicine, Gartnavel General Hospital, Glasgow, UK, UK)
Closing Remarks